The Cross-Sectional Evaluation of the Use of Artemisinin-Based Combination Therapy for Treatment of Malaria Infection at a Tertiary Hospital in Nigeria

Figure 1

Drug utilization ninety percent (DU90%) of antimalarials. Antimalarial regimen listed in the NATG. Antimalarial regimens that are not listed in the NATG, but can be referred to as “recommended” treatment as they contain an artemisinin derivative and partner drug. Adherence: Based on antimalarial regimens listed in the NATG. Adjusted Adherence: Based on all ACTs.